Cumberland Pharmaceuticals Inc. Common Stock (CPIX)
Stock · NASDAQ · Health Care
$7.22as of 10/16/2026
Price chart
Active signals
CPIX Signal Track Record
How signals performed across all stocks →What CPIX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | +2.8% | 55% | October 1, 2026 |
| Bollinger Band Breakout | 25 | +1.2% | 56% | August 4, 2026 |
| Bollinger Band Breakdown | 19 | -2.1% | 47% | August 31, 2026 |
| 200-Day Moving Average TouchActive now | 10 | +1.4% | 50% | January 26, 2026 |
| Any 20-session window (baseline) | -0.7% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 88
- Website
- www.cumberlandpharma.com/
Fundamentals
- 1-day range
- $7$7.58
- Market cap
- $115.07M
- P/E (trailing)
- —
- P/E (forward)
- 51.29
- EPS (trailing)
- $-0.72
- Dividend yield
- —
- Beta
- 0.19
- Avg. volume
- 79.3K
- Ex-dividend date
- August 3, 2026
- Dividend pay date
- July 31, 2026
How Cumberland Pharmaceuticals Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 9, 2026 · via SEC EDGAR / Finnhub
Cumberland Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CPIXCumberland Pharmaceuticals Inc. Common Stock$7.18▼ 4.77%Market cap $115.07MP/E —$1.85$9.28
- CUECue Biopharma Inc. Common Stock$16.71▼ 10.50%Market cap $113.45MP/E —$4.97$45.5
- ANIXAnixa Biosciences Inc. Common Stock$2.67▼ 3.96%Market cap $116.70MP/E —$2.32$5.46
- YARWYarrow Bioscience Inc. Common Stock$18.31▼ 8.45%Market cap $116.71MP/E —$18.16$44.28
- NRXPNRX Pharmaceuticals Inc. Common Stock$2.6▼ 4.06%Market cap $111.95MP/E —$1.62$5.06
- BGMBGM Group Ltd. Class A Ordinary Shares$8.65▲ 0.70%Market cap $118.62MP/E —$6.45$303
- PLYXPolaryx Therapeutics Inc. Common Stock$1.88▼ 3.59%Market cap $110.66MP/E —$1.85$48.91
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CPIX Cumberland Pharmaceuticals Inc. Common Stock | $115.07M | — | $7.18 | ▼ 4.77% | $1.85$9.28 |
| CUE Cue Biopharma Inc. Common Stock | $113.45M | — | $16.71 | ▼ 10.50% | $4.97$45.5 |
| ANIX Anixa Biosciences Inc. Common Stock | $116.70M | — | $2.67 | ▼ 3.96% | $2.32$5.46 |
| YARW Yarrow Bioscience Inc. Common Stock | $116.71M | — | $18.31 | ▼ 8.45% | $18.16$44.28 |
| NRXP NRX Pharmaceuticals Inc. Common Stock | $111.95M | — | $2.6 | ▼ 4.06% | $1.62$5.06 |
| BGM BGM Group Ltd. Class A Ordinary Shares | $118.62M | — | $8.65 | ▲ 0.70% | $6.45$303 |
| PLYX Polaryx Therapeutics Inc. Common Stock | $110.66M | — | $1.88 | ▼ 3.59% | $1.85$48.91 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 2.87M
- Total value held
- $9.17M
- Institutional holders
- 29
- Unknown553.2K
- Unknown470.7K
- Unknown361.8K
- Unknown276.4K
- Unknown197.0K
- Unknown163.5K
- Unknown127.7K
- Unknown114.3K
- Unknown81.0K
- Unknown73.5K
See the full, filterable feed with live charts on the MarketWall dashboard.